The "Silent Partner" in a Breakthrough Cancer Therapy
A small biotech company in Europe developed a promising new cancer therapy. They needed to conduct a multi-center clinical trial across several European countries, but they lacked the internal resources to manage the complex translation requirements. We stepped in as their "silent partner," providing seamless translation of all trial materials, from the initial protocol to the final patient-reported outcomes. The result? The trial was completed on time and within budget, and the therapy is now saving lives around the world. What makes this story special is that we became an extension of their team, working closely with their scientists and clinicians to ensure that every translation was not only accurate but also sensitive to the needs of the patients involved. We celebrated their success as if it were our own.





Other Cases
From Global Markets to a Single Word: Our Work with GENERAL MEDITECH, INC.
When GENERAL MEDITECH, INC. prepared to launch their line of Pulse Oximeters...
IQVIA: Mastering Global Clinical Trial Communication
A Partnership Spotlight on Scale & Multi-Language Complexity...
ICON: A Partnership Built on Reliability and Speed
A Partnership Spotlight on Efficiency & Trust...